The company's vascular grafts are three-layered semi-resorbable devices that integrate into the bodies of hemodialytic patients, providing a hybrid material that combines the elasticity and stability of polyurethanes with the remodeling capabilities of silk fibroin. Dialybrid aims to improve the quality of life for patients by offering products such as silkothane arteriovenous grafts, SAG biomimetic nanostructures, and situ tissue engineering products. Based in Milan, Italy, their goal is to develop a semi-degradable vascular access solution for hemodialysis.